Letko, Brosseau & Associates Inc Moderna, Inc. Transaction History
Letko, Brosseau & Associates Inc
- $5.03 Billion
- Q4 2024
A detailed history of Letko, Brosseau & Associates Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Letko, Brosseau & Associates Inc holds 923,345 shares of MRNA stock, worth $33.1 Million. This represents 0.76% of its overall portfolio holdings.
Number of Shares
923,345
Previous 511,145
80.64%
Holding current value
$33.1 Million
Previous $34.2 Million
12.39%
% of portfolio
0.76%
Previous 0.64%
Shares
5 transactions
Others Institutions Holding MRNA
# of Institutions
919Shares Held
255MCall Options Held
19MPut Options Held
24.2M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.45 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.4 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$918 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$631 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$262 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $14B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...